We are live on ! Find out more
SLDB icon

Solid Biosciences
SLDB

77 hedge funds and large institutions have $83.2M invested in Solid Biosciences in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 35 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

532% more call options, than puts

Call options by funds: $120K | Put options by funds: $19K

0.38% less ownership

Funds ownership: 4.57% → 4.18% (-0.38%)

6% less funds holding

Funds holding: 82 → 77 (-5)

27% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 15

37% less capital invested

Capital invested by funds: $132M → $83.2M (-$49M)

60% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 35

Holders
77
Holders Change
-5
Holders Change %
-6.1%
% of All Funds
1.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
14
Reduced
35
Closed
15
Calls
$120K
Puts
$19K
Net Calls
+$101K
Net Calls Change
+$230K

Top Buyers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
+$2.54M
2
SCM
Suvretta Capital Management
New York
+$1.1M
3
Renaissance Technologies
Renaissance Technologies
New York
+$777K
4
AQR Capital Management
AQR Capital Management
Connecticut
+$366K
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$353K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$7.81M
2
Millennium Management
Millennium Management
New York
-$644K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$545K
4
BlackRock
BlackRock
New York
-$507K
5
N
Nuveen
North Carolina
-$475K
Name Holding Trade Value Shares
Change 		Change in
Stake
CANY
76
Caxton Associates (New York)
New York
– -$311K -11,838 Closed
Acadian Asset Management
77
Acadian Asset Management
Massachusetts
– -$214K -8,227 Closed
PAM
78
Panagora Asset Management
Massachusetts
– -$213K -8,120 Closed
GCP
79
GSA Capital Partners
United Kingdom
– -$198K -7,540 Closed
ECM
80
ExodusPoint Capital Management
New York
– -$112K -4,272 Closed
B
81
Bailard
California
– -$93K -3,560 Closed
Assenagon Asset Management
82
Assenagon Asset Management
Luxembourg
– -$45K -1,726 Closed
CPIG
83
Chicago Partners Investment Group
Illinois
– -$20K -1,266 Closed
CSS
84
Cubist Systematic Strategies
Connecticut
– -$33K -1,248 Closed
SG Americas Securities
85
SG Americas Securities
New York
– -$30K -1,125 Closed
NDSI
86
Newman Dignan & Sheerar Inc
Rhode Island
– -$21K -802 Closed
TSS
87
Two Sigma Securities
New York
– -$20K -762 Closed
JFA
88
JNBA Financial Advisors
Minnesota
– -$14K -533 Closed
Osaic Holdings
89
Osaic Holdings
Arizona
– +$124 +7 +29%
PA
90
Parallel Advisors
California
– +$124 +7 New
1 2 3
4

SLDB Hedge Fund Activity: Q1 2022 in Review

77 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q1 2022, worth a combined $83.2M — down 37% from $132M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of SLDB and 11 opened new positions — a net loss of 4 holders — while 35 trimmed existing stakes and 14 added.

The largest buyer was Boxer Capital, adding an estimated $2.54M. The largest seller was EcoR1 Capital, cutting an estimated $7.81M.

  • 77 institutional investors held Solid Biosciences (SLDB) as of Q1 2022, down from 82 in Q4 2021.
  • Funds reported $83.2M of Solid Biosciences stock for Q1 2022, down 37% quarter-over-quarter.
  • 11 funds opened new Solid Biosciences positions in Q1 2022 and 15 closed out, a net change of -4 holders.
  • The largest Solid Biosciences buyer in Q1 2022 was Boxer Capital, an estimated $2.54M added.
  • The largest Solid Biosciences seller in Q1 2022 was EcoR1 Capital, an estimated $7.81M sold.

Based on aggregated 13F filings for Q1 2022.